Role of PPAR alpha in the mechanism of action of the nongenotoxic carcinogen and peroxisome proliferator Wy-14,643 - PubMed (original) (raw)
Role of PPAR alpha in the mechanism of action of the nongenotoxic carcinogen and peroxisome proliferator Wy-14,643
J M Peters et al. Carcinogenesis. 1997 Nov.
Abstract
Chronic administration of peroxisome proliferators to mice and rats results in hepatomegaly and ultimately carcinogenesis. The mechanism underlying the carcinogenic effect of nongenotoxic peroxisome proliferators is not well understood. To determine whether nongenotoxic carcinogenesis is receptor mediated, we evaluated the effect of the prototypical peroxisome proliferator Wy-14,643 on replicative DNA synthesis and carcinogenesis in the PPAR alpha-null mouse line. Male mice (F4, Sv/129 ter) of both genotypes (+/+) and (-/-) were fed either a control diet or one containing 0.1% Wy-14,643 for either 1 week, 5 weeks, or 11 months. Wild-type mice fed the Wy-14,643 diet for 1 or 5 weeks showed increased hepatic labeling by bromodeoxyuridine (BrDU) compared to untreated controls. In contrast, there was no increase in hepatic BrDU labeling index in (-/-) mice fed the Wy-14,643 diet for the same time periods compared to controls. After 11 months, 100% of the (+/+) mice fed the Wy-14,643 diet had multiple hepatocellular neoplasms, including adenomas and carcinomas, while the (-/-) mice fed the Wy-14,643 diet were unaffected. This work demonstrates that the effects of Wy-14,643 on replicative DNA synthesis and hepatocarcinogenesis are mediated by PPAR alpha.
Similar articles
- Dietary glycine prevents increases in hepatocyte proliferation caused by the peroxisome proliferator WY-14,643.
Rose ML, Germolec D, Arteel GE, Schoonhoven R, Thurman RG. Rose ML, et al. Chem Res Toxicol. 1997 Oct;10(10):1198-204. doi: 10.1021/tx970079u. Chem Res Toxicol. 1997. PMID: 9348444 - PPAR: a mediator of peroxisome proliferator action.
Green S. Green S. Mutat Res. 1995 Dec;333(1-2):101-9. doi: 10.1016/0027-5107(95)00136-0. Mutat Res. 1995. PMID: 8538617 Review. - Mechanism of action of the nongenotoxic peroxisome proliferators: role of the peroxisome proliferator-activator receptor alpha.
Gonzalez FJ, Peters JM, Cattley RC. Gonzalez FJ, et al. J Natl Cancer Inst. 1998 Nov 18;90(22):1702-9. doi: 10.1093/jnci/90.22.1702. J Natl Cancer Inst. 1998. PMID: 9827524 Review.
Cited by
- Dietary saturated fatty acids reduce hepatic lipid accumulation but induce fibrotic change in alcohol-fed rats.
Chen YL, Peng HC, Wang XD, Yang SC. Chen YL, et al. Hepatobiliary Surg Nutr. 2015 Jun;4(3):172-83. doi: 10.3978/j.issn.2304-3881.2015.01.04. Hepatobiliary Surg Nutr. 2015. PMID: 26151057 Free PMC article. - Mechanistic considerations for human relevance of cancer hazard of di(2-ethylhexyl) phthalate.
Rusyn I, Corton JC. Rusyn I, et al. Mutat Res. 2012 Apr-Jun;750(2):141-158. doi: 10.1016/j.mrrev.2011.12.004. Epub 2011 Dec 20. Mutat Res. 2012. PMID: 22198209 Free PMC article. Review. - Effect of prenatal peroxisome proliferator-activated receptor alpha (PPARalpha) agonism on postnatal development.
Palkar PS, Anderson CR, Ferry CH, Gonzalez FJ, Peters JM. Palkar PS, et al. Toxicology. 2010 Sep 30;276(1):79-84. doi: 10.1016/j.tox.2010.07.008. Epub 2010 Jul 15. Toxicology. 2010. PMID: 20637823 Free PMC article. - PPARalpha- and DEHP-Induced Cancers.
Ito Y, Nakajima T. Ito Y, et al. PPAR Res. 2008;2008:759716. doi: 10.1155/2008/759716. PPAR Res. 2008. PMID: 18769559 Free PMC article. - Inhibition of PPARα induces cell cycle arrest and apoptosis, and synergizes with glycolysis inhibition in kidney cancer cells.
Abu Aboud O, Wettersten HI, Weiss RH. Abu Aboud O, et al. PLoS One. 2013 Aug 7;8(8):e71115. doi: 10.1371/journal.pone.0071115. eCollection 2013. PLoS One. 2013. PMID: 23951092 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources